S&P 500   3,784.31 (+2.88%)
DOW   30,268.85 (+2.64%)
QQQ   281.49 (+2.91%)
AAPL   145.78 (+2.34%)
MSFT   248.24 (+3.12%)
META   140.02 (+1.02%)
GOOGL   101.40 (+2.80%)
AMZN   120.86 (+4.30%)
TSLA   248.26 (+2.42%)
NVDA   131.11 (+4.79%)
NIO   16.67 (+7.62%)
BABA   84.05 (+4.47%)
AMD   67.92 (+2.74%)
T   16.09 (+1.19%)
MU   53.95 (+4.31%)
CGC   3.14 (+7.90%)
F   12.32 (+7.41%)
GE   67.31 (+5.83%)
DIS   101.02 (+4.00%)
AMC   7.82 (+13.66%)
PYPL   92.81 (+6.46%)
PFE   44.44 (+0.68%)
NFLX   239.57 (+0.22%)
S&P 500   3,784.31 (+2.88%)
DOW   30,268.85 (+2.64%)
QQQ   281.49 (+2.91%)
AAPL   145.78 (+2.34%)
MSFT   248.24 (+3.12%)
META   140.02 (+1.02%)
GOOGL   101.40 (+2.80%)
AMZN   120.86 (+4.30%)
TSLA   248.26 (+2.42%)
NVDA   131.11 (+4.79%)
NIO   16.67 (+7.62%)
BABA   84.05 (+4.47%)
AMD   67.92 (+2.74%)
T   16.09 (+1.19%)
MU   53.95 (+4.31%)
CGC   3.14 (+7.90%)
F   12.32 (+7.41%)
GE   67.31 (+5.83%)
DIS   101.02 (+4.00%)
AMC   7.82 (+13.66%)
PYPL   92.81 (+6.46%)
PFE   44.44 (+0.68%)
NFLX   239.57 (+0.22%)
S&P 500   3,784.31 (+2.88%)
DOW   30,268.85 (+2.64%)
QQQ   281.49 (+2.91%)
AAPL   145.78 (+2.34%)
MSFT   248.24 (+3.12%)
META   140.02 (+1.02%)
GOOGL   101.40 (+2.80%)
AMZN   120.86 (+4.30%)
TSLA   248.26 (+2.42%)
NVDA   131.11 (+4.79%)
NIO   16.67 (+7.62%)
BABA   84.05 (+4.47%)
AMD   67.92 (+2.74%)
T   16.09 (+1.19%)
MU   53.95 (+4.31%)
CGC   3.14 (+7.90%)
F   12.32 (+7.41%)
GE   67.31 (+5.83%)
DIS   101.02 (+4.00%)
AMC   7.82 (+13.66%)
PYPL   92.81 (+6.46%)
PFE   44.44 (+0.68%)
NFLX   239.57 (+0.22%)
S&P 500   3,784.31 (+2.88%)
DOW   30,268.85 (+2.64%)
QQQ   281.49 (+2.91%)
AAPL   145.78 (+2.34%)
MSFT   248.24 (+3.12%)
META   140.02 (+1.02%)
GOOGL   101.40 (+2.80%)
AMZN   120.86 (+4.30%)
TSLA   248.26 (+2.42%)
NVDA   131.11 (+4.79%)
NIO   16.67 (+7.62%)
BABA   84.05 (+4.47%)
AMD   67.92 (+2.74%)
T   16.09 (+1.19%)
MU   53.95 (+4.31%)
CGC   3.14 (+7.90%)
F   12.32 (+7.41%)
GE   67.31 (+5.83%)
DIS   101.02 (+4.00%)
AMC   7.82 (+13.66%)
PYPL   92.81 (+6.46%)
PFE   44.44 (+0.68%)
NFLX   239.57 (+0.22%)
OTCMKTS:PROT

Proteonomix - PROT Stock Forecast, Price & News

Add
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
25,809 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Proteonomix

Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives. The company's products include Proteoderm, an anti-aging skin cream based on a proprietary and patented matrix of proteins that reduce wrinkles; UMK-121, a treatment for liver disease using a combination of two or three approved drugs to mobilize particular bone marrow stem cells; and StromaCel, a treatment for cardiac patients within two weeks of a myocardial infarction using stem cells derived from donor bone marrow and administered through IV solution to repair heart tissue. Its products also comprise NC-138, a proprietary matrix of proteins, which act on the skin to enhance activities that reduce wrinkles. The company was formerly known as National Stem Cell Holding, Inc. and changed its name to Proteonomix, Inc. in August 2008. Proteonomix, Inc. was incorporated in 1995 and is based in Hawthorne, New Jersey.

Receive PROT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Proteonomix and its competitors with MarketBeat's FREE daily newsletter.

PROT Stock News Headlines

PROT.PK - | Stock Price & Latest News | Reuters
PreVu, Inc. (PRVU)
See More Headlines

Receive PROT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Proteonomix and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:PROT
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Michael Cohen (Age 55)
    Founder, Chairman, CEO, Pres & COO
  • Mr. Steven Byle (Age 54)
    CTO & Director
  • Mr. Jason B. Isaacs (Age 50)
    Sec.
  • Ms. Jaci Mandil
    Chief Exec. Officer of Proteoderm













PROT Stock - Frequently Asked Questions

What is Proteonomix's stock symbol?

Proteonomix trades on the OTCMKTS under the ticker symbol "PROT."

How do I buy shares of Proteonomix?

Shares of PROT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How can I contact Proteonomix?

Proteonomix's mailing address is 187 Mill Ln, MOUNTAINSIDE, NJ 07092-2918, United States. The official website for the company is stromacel.com. The biotechnology company can be reached via phone at (973) 949-4195.

This page (OTCMKTS:PROT) was last updated on 10/4/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.